FILTER

FILTERED INTERVIEW RESULTS

Karen Fallen

SENIOR VICE PRESIDENT: BUSINESS UNIT HEAD - CLINICAL DEVELOPMENT & MANUFACTURING, LONZA
Lonza is one of the world's leading suppliers to the pharma, biotech and specialty ingredient markets.

Shabbir Dahod

PRESIDENT AND CEO, TRACELINK
TraceLink is the world’s largest integrated digital supply network connecting the life sciences supply chain.

Christiana Goh Bardon

MD, MBA, MANAGING DIRECTOR, UBS ONCOLOGY IMPACT FUND MANAGED BY MPM CAPITAL & PORTFOLIO MANAGER, BURRAGE CAPITAL FUND
UBS Oncology Impact Fund is an evergreen fund specializing in investments in early stage oncology and cancer therapeutics.

Geoff Meyerson

CEO AND CO-FOUNDER, LOCUST WALK
Locust Walk is a global life science transaction firm with an integrated team-based approach across capabilities, geographies, and industry segments to deliver the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.

Jonathan Retano

FOUNDER AND CEO, PHARMAFUSION
Pharmafusion provides data warehouse and business analytics solutions for the pharmaceutical industry.

John Patrick Oroho

EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER AT PORZIO LIFE SCIENCES
Porzio Life Sciences is dedicated to helping pharmaceutical, medical device and biotechnology organizations master the evolving regulatory environment.

Paul Hennessey

SENIOR VP SALES, CONTRACT PHARMACAL CORP. (CPC)
Contract Pharmacal Corp. manufactures and packages pharmaceuticals, over-the-counter drugs and dietary supplements.

Robert K. Coughlin

PRESIDENT & CEO, MASSBIO
MassBio’s mission is to advance Massachusetts' leadership in life sciences to grow the industry, add value to the healthcare system and improve patient lives.

Jennifer Hawks Bland

CEO, NEWYORKBIO
NewYorkBIO brings together New York’s bioscience stakeholders to advance life science research and commercialization.

Eric Falcand

VICE PRESIDENT, HEAD OF BUSINESS DEVELOPMENT AND LICENSING, SERVIER GROUP
Servier is strengthening its oncology portfolio and widneing its U.S. footprint.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

MACIG West Africa 2021-2022

PARTNER EVENTS